| Tretinoin | Approved Investigational Nutraceutical | MFAP4 | 4239 |
downregulated | Tretinoin results in decreased expression of MFAP4 mRNA | 17p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MFAP5 | 8076 |
upregulated | Tretinoin results in increased expression of MFAP5 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MFNG | 4242 |
downregulated | Tretinoin results in decreased expression of MFNG mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MFSD1 | 64747 |
upregulated | Tretinoin results in increased expression of MFSD1 mRNA | 3q25.32 | |
| Tretinoin | Approved Investigational Nutraceutical | MFSD10 | 10227 |
upregulated | Tretinoin results in increased expression of MFSD10 mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MGARP | 84709 |
upregulated | Tretinoin results in increased expression of MGARP mRNA | 4q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MGAT4A | 11320 |
upregulated | Tretinoin results in increased expression of MGAT4A mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MGAT4C | 25834 |
upregulated | Tretinoin results in increased expression of MGAT4C mRNA | 12q21.31-q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | MGAT5 | 4249 |
downregulated | Tretinoin results in decreased expression of MGAT5 mRNA | 2q21.2-q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MGEA5 | 10724 |
downregulated | Tretinoin results in decreased expression of MGEA5 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | MGEA5 | 10724 |
upregulated | Tretinoin results in increased expression of MGEA5 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | MGLL | 11343 |
downregulated | Tretinoin results in decreased expression of MGLL mRNA | 3q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MGP | 4256 |
upregulated | Tretinoin results in increased expression of MGP mRNA | 12p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MGST1 | 4257 |
downregulated | Tretinoin results in decreased expression of MGST1 mRNA | 12p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MIAT | 440823 |
downregulated | Tretinoin results in decreased expression of MIAT mRNA | 22q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MICALCL | 84953 |
downregulated | Tretinoin results in decreased expression of MICALCL mRNA | 11p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MID2 | 11043 |
upregulated | Tretinoin results in increased expression of MID2 mRNA | Xq22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MIF | 4282 |
upregulated | Tretinoin results in increased expression of MIF mRNA | 22q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | MIOS | 54468 |
downregulated | Tretinoin results in decreased expression of MIOS mRNA | 7p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MIR106A | 406899 |
downregulated | Tretinoin results in decreased expression of MIR106A mRNA | Xq26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MIR107 | 406901 |
upregulated | Tretinoin results in increased expression of MIR107 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MIR10A | 406902 |
upregulated | Tretinoin results in increased expression of MIR10A mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | MIR10B | 406903 |
upregulated | Tretinoin results in increased expression of MIR10B mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MIR129-1 | 406917 |
downregulated | Tretinoin results in decreased expression of MIR129-1 mRNA | 7q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MIR132 | 406921 |
upregulated | Tretinoin results in increased expression of MIR132 mRNA | 17p13.3 | |